{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:45:49Z","timestamp":1770270349525,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.clml.2018.12.016","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T20:36:25Z","timestamp":1546461385000},"page":"244-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue"],"prefix":"10.1016","volume":"19","author":[{"given":"Ethan B.","family":"Ludmir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Milgrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea C.","family":"Pinnix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian R.","family":"Gunther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Westin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouthaina S.","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta J.","family":"Nastoupil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.12.016_bib1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ctrv.2014.05.010","article-title":"Primary breast lymphoma","volume":"40","author":"Cheah","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clml.2018.12.016_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clbc.2012.07.006","article-title":"Treatment and outcomes of primary breast lymphoma","volume":"126","author":"Caon","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clml.2018.12.016_bib3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0b013e318165eb50","article-title":"Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms","volume":"32","author":"Talwalkar","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2018.12.016_bib4","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/annonc\/mdt192","article-title":"Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options","volume":"24","author":"Aviv","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw294","article-title":"Primary breast lymphoma in the United States: 1975-2013","volume":"109","author":"Thomas","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2018.12.016_bib6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/modpathol.3800668","article-title":"MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast","volume":"19","author":"Talwalkar","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2018.12.016_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000421-199808000-00012","article-title":"Localized primary non-Hodgkin lymphoma of the breast","volume":"21","author":"Ha","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib8","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/annonc\/mdp238","article-title":"Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group","volume":"20","author":"Martinelli","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2015.01.040","article-title":"Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent","volume":"92","author":"Teckie","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2018.12.016_bib10","first-page":"153","article-title":"Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"66","author":"Raderer","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2018.12.016_bib11","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.12.016_bib12","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/sj.leu.2404782","article-title":"MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course","volume":"21","author":"W\u00f6hrer","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.12.016_bib13","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","article-title":"A\u00a0MALT lymphoma prognostic index","volume":"130","author":"Thieblemont","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.12.016_bib14","series-title":"Common Terminology Criteria for Adverse Events v4.0. NIH Publication #09-7473","year":"2009"},{"key":"10.1016\/j.clml.2018.12.016_bib15","series-title":"IBM SPSS Statistics for Windows, Version 22.0","year":"2013"},{"key":"10.1016\/j.clml.2018.12.016_bib16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/annonc\/mdx025","article-title":"Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma","volume":"28","author":"Teckie","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3109\/10428190109097740","article-title":"Breast MALT lymphoma: potential relationship between hormonal environment and female sex hormone receptor expression in lymphoma cell","volume":"42","author":"Hakoda","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.12.016_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hed.24717","article-title":"Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma","volume":"30","author":"Pinnix","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.clml.2018.12.016_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00066-018-1277-3","article-title":"Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas","volume":"194","author":"K\u00f6nig","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clml.2018.12.016_bib22","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.12.016_bib23","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1080\/10428190701457949","article-title":"Rituximab for treatment of chemoimmunotherapy-naive marginal-zone lymphoma","volume":"48","author":"Lossos","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.12.016_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/annonc\/mdn636","article-title":"Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients","volume":"20","author":"Valencak","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.12.016_bib26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.sla.0000254418.90192.59","article-title":"Primary breast lymphoma: the role of mastectomy and the importance of lymph node status","volume":"245","author":"Jennings","year":"2007","journal-title":"Ann Surg"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018314460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018314460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:32:02Z","timestamp":1761870722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018314460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2152265018314460"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.12.016","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}